Acute Myeloid Leukemia with Translocation

• CLINICAL_TRIALS research · 2025-08-28
  Clinical Trial Update: Treatment of Relapsed or Refractory t(8; 21) AML With Targeted AML1-ETO Neoantigen Cytotoxic T Cells (CTL) [EARLY_Phase 1]

  An early-phase 1 trial is evaluating targeted AML1-ETO neoantigen cytotoxic T cells for relapsed or refractory acute myeloid leukemia with t…

• CLINICAL_TRIALS withdrawal · 2025-05-01
  Clinical Trial Update: Dasatinib Combined With Chemotherapy in Relapsed t(8;21) Acute Myeloid Leukemia With KIT D816 Mutation [Phase 1]

  Phase 1 trial evaluating dasatinib in combination with chemotherapy for relapsed acute myeloid leukemia with t(8;21) translocation and KIT D…

• CLINICAL_TRIALS trial_result · 2014-02-06
  Clinical Trial Update: Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia [Phase 2]

  A Phase 2 trial evaluating bortezomib in combination with chemotherapy for younger patients with recurrent, refractory, or secondary acute m…